Sanofi Expects Stronger Sales Of H1N1 Vaccine In 1Q Than 4Q
30 Octubre 2009 - 8:58AM
Noticias Dow Jones
Sanofi-Aventis (SNY) expects to generate more sales of its swine
flu H1N1 vaccine in the first quarter of 2010 than in the last
quarter of 2009, company executives said Friday on a conference
call on third-quarter results.
Sanofi expects to make over $500 million in sales of the vaccine
in the fourth quarter.
Chief Executive Chris Viehbacher said that the sales boost from
the swine flu vaccine could continue into April of next year.
Company web site: www.sanofi-aventis.com
-By Mimosa Spencer, Dow Jones Newswires; +33 1 40 17 17 73;
mimosa.spencer@dowjones.com